Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem Cell Therapy Life Science Investing
Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Formal Take-over Bid to Commence on January 23, 2019; Receives Commitment for C$150 Million Equity Investment Cannabis Investing News
Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial Life Science Investing
Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis Life Science Investing
